The novel long acting ENaC blocker P643 has therapeutic effects in chronic cystic fibrosis-like lung disease in mice
Zhou, Z, Harm, M, Treis, D.A, Schubert, S.C, Schatterny, J, Hirtz, S, Duerr, J, Hirsh, A.J, Ross Johnson, M, Boucher, R.C, Mall, M.A
Published in Journal of cystic fibrosis (2009)
Published in Journal of cystic fibrosis (2009)
Get full text
Journal Article
The CF Salt Controversy: In Vivo Observations and Therapeutic Approaches
Tarran, R, Grubb, B.R, Parsons, D, Picher, M, Hirsh, A.J, Davis, C.W, Boucher, R.C
Published in Molecular cell (01.07.2001)
Published in Molecular cell (01.07.2001)
Get full text
Journal Article
The CF Salt Controversy
Tarran, R, Grubb, B.R, Parsons, D, Picher, M, Hirsh, A.J, Davis, C.W, Boucher, R.C
Published in Molecular cell (01.07.2001)
Published in Molecular cell (01.07.2001)
Get full text
Journal Article